Index
1 Market Overview of Alzheimer’s Disease Therapeutics and Diagnostics
1.1 Alzheimer’s Disease Therapeutics and Diagnostics Market Overview
1.1.1 Alzheimer’s Disease Therapeutics and Diagnostics Product Scope
1.1.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Status and Outlook
1.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2018-2029)
1.4 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Region (2018-2023)
1.5 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2018-2029)
1.6.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2018-2029)
1.6.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2018-2029)
1.6.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2018-2029)
1.6.4 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2018-2029)
1.6.5 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size (2018-2029)
2 Alzheimer’s Disease Therapeutics and Diagnostics Market by Type
2.1 Introduction
2.1.1 Diagnostics
2.1.2 Treatment
2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Type (2018-2023)
2.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Type (2018-2029)
3 Alzheimer’s Disease Therapeutics and Diagnostics Market Overview by Application
3.1 Introduction
3.1.1 Marketed Drugs
3.1.2 Pipeline Drugs
3.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Historic Market Size by Application (2018-2023)
3.2.2 Global Alzheimer’s Disease Therapeutics and Diagnostics Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Alzheimer’s Disease Therapeutics and Diagnostics Revenue Breakdown by Application (2018-2029)
4 Alzheimer’s Disease Therapeutics and Diagnostics Competition Analysis by Players
4.1 Global Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Alzheimer’s Disease Therapeutics and Diagnostics as of 2022)
4.3 Date of Key Players Enter into Alzheimer’s Disease Therapeutics and Diagnostics Market
4.4 Global Top Players Alzheimer’s Disease Therapeutics and Diagnostics Headquarters and Area Served
4.5 Key Players Alzheimer’s Disease Therapeutics and Diagnostics Product Solution and Service
4.6 Competitive Status
4.6.1 Alzheimer’s Disease Therapeutics and Diagnostics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.1.4 Pfizer Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Eisai
5.2.1 Eisai Profile
5.2.2 Eisai Main Business
5.2.3 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.2.4 Eisai Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.2.5 Eisai Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.3.4 Novartis Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.3.5 Forest Laboratories Recent Developments
5.4 Forest Laboratories
5.4.1 Forest Laboratories Profile
5.4.2 Forest Laboratories Main Business
5.4.3 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.4.4 Forest Laboratories Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.4.5 Forest Laboratories Recent Developments
5.5 TauRx Therapeutics
5.5.1 TauRx Therapeutics Profile
5.5.2 TauRx Therapeutics Main Business
5.5.3 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.5.4 TauRx Therapeutics Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.5.5 TauRx Therapeutics Recent Developments
5.6 AC Immune
5.6.1 AC Immune Profile
5.6.2 AC Immune Main Business
5.6.3 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.6.4 AC Immune Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.6.5 AC Immune Recent Developments
5.7 Johnson & Johnson.
5.7.1 Johnson & Johnson. Profile
5.7.2 Johnson & Johnson. Main Business
5.7.3 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.7.4 Johnson & Johnson. Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.7.5 Johnson & Johnson. Recent Developments
5.8 H. Lundbeck
5.8.1 H. Lundbeck Profile
5.8.2 H. Lundbeck Main Business
5.8.3 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Products, Services and Solutions
5.8.4 H. Lundbeck Alzheimer’s Disease Therapeutics and Diagnostics Revenue (US$ Million) & (2018-2023)
5.8.5 H. Lundbeck Recent Developments
6 North America
6.1 North America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Therapeutics and Diagnostics Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Alzheimer’s Disease Therapeutics and Diagnostics Market Dynamics
11.1 Alzheimer’s Disease Therapeutics and Diagnostics Industry Trends
11.2 Alzheimer’s Disease Therapeutics and Diagnostics Market Drivers
11.3 Alzheimer’s Disease Therapeutics and Diagnostics Market Challenges
11.4 Alzheimer’s Disease Therapeutics and Diagnostics Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List